Format

Send to

Choose Destination
EMBO Mol Med. 2013 Jun;5(6):795-8. doi: 10.1002/emmm.201202307. Epub 2013 May 23.

Next generation therapeutics for Alzheimer's disease.

Author information

1
Buck Institute for Research on Aging, Novato, CA, USA. dbredesen@buckinstitute.org

Abstract

To date, no truly effective therapy has been developed for Alzheimer's disease or mild cognitive impairment. In searching for new approaches that may succeed where previous ones have failed, it may be instructive to consider the successful therapeutic developments for other chronic illnesses such as cancer and human immunodeficiency virus.

PMID:
23703924
PMCID:
PMC3779441
DOI:
10.1002/emmm.201202307
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center